JPMORGAN CHASE & CO - AVEO PHARMACEUTICALS INC ownership

AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 79 filers reported holding AVEO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of AVEO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$2,580
+158.0%
172,658
+172558.0%
0.00%
Q3 2022$1,0000.0%100
+5.3%
0.00%
Q2 2022$1,0000.0%950.0%0.00%
Q1 2022$1,000950.0%0.00%
Q4 2021$0
-100.0%
950.0%0.00%
Q3 2021$1,0000.0%950.0%0.00%
Q2 2021$1,000
-98.3%
95
-98.8%
0.00%
Q1 2021$60,000
-90.1%
8,248
-92.2%
0.00%
Q4 2020$607,000
+131.7%
105,226
+132.4%
0.00%
Q3 2020$262,000
+991.7%
45,272
+889.3%
0.00%
Q2 2020$24,0004,5760.00%
Other shareholders
AVEO PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,952,958$22,809,0000.60%
SECTORAL ASSET MANAGEMENT INC 1,151,175$6,642,0000.47%
X-Square Capital, LLC 75,952$438,0000.24%
SABBY MANAGEMENT, LLC 68,092$393,0000.08%
WealthTrust Axiom LLC 22,347$128,0000.05%
Opaleye Management Inc. 58,800$339,0000.04%
Trexquant Investment LP 64,838$374,0000.04%
PDT Partners, LLC 60,117$347,0000.02%
PERSONAL CFO SOLUTIONS, LLC 13,000$75,0000.02%
CVI Holdings, LLC 13,171$76,0000.01%
View complete list of AVEO PHARMACEUTICALS INC shareholders